SCHEMBL368738

SCHEMBL368738

Cn1ncc(Cl)c1-c1ccccc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.45
IDO1 P14902 4/20 0.44
HTR2A P28223 4/20 0.40
HTR2C P28335 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2064595 0.78 CA1 (0.44) IDO1HTR2AHTR2CKMT2AMAPT
SCHEMBL3917369 0.73 HTR2A (0.45) HTR2AHTR2CMAPTHPGDSMN1; SMN2
SCHEMBL17026307 0.71 ALDH1A1 (0.41) HIF1AHTR2AHTR2CKMT2AMAPT
SCHEMBL23401726 0.70 HIF1A (0.46) HIF1AIDO1KMT2AMAPTHPGD
Chloromethane SCHEMBL28296460 0.70 ALDH1A1 (0.57) HIF1AIDO1KMT2AMAPTHPGD
SCHEMBL23087496 0.69 HSD11B1 (0.49) HIF1AHTR2AHTR2CKMT2AHSD11B1
SCHEMBL17026201 0.68 HTR2A (0.45) HTR2AHTR2CKMT2AMAPTHPGD
SCHEMBL12528334 0.68 HIF1A (0.44) HIF1AKMT2AMAPTHPGDALDH1A1
SCHEMBL949842 0.68 ALDH1A1 (0.47) HIF1AKMT2AALDH1A1KDM4EHSD11B1
SCHEMBL12681326 0.68 GAA (0.40) HIF1AHTR2AHTR2CKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 EP disclosed
EP-2593427-A1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN Pfizer Limited (GB) 2013-05-22 EP disclosed
WO-2012007883-A1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LIMITED (GB) 2012-01-19 WO disclosed
US-20120010207-A1 Chemical Compounds PFIZER LIMITED (GB) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010207-A1 Chemical Compounds SCN1A, SCN1B, SCN7A HIF1A 763/4885IDO1 3277/4885HTR2A 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.